How Olivia Munn’s doctor knew she was at risk for breast cancer

Deborah Farr, M.D. is a surgical oncologist who specializes in treating breast cancer. When Dr. Farr heard about Olivia Munn’s diagnosis, she immediately knew what tool gave her the lifesaving information that she needed. “The breast cancer risk assessment tool…

Yale Cancer Center experts present new research on obesity, tobacco, evolution, and early onset cancers at leading oncology conference

Yale Cancer Center (YCC) and Smilow Cancer Hospital physicians and scientists will share new data for breakthrough and emerging cancer treatments as well as new discoveries in obesity, tobacco, evolution, and early onset cancers in early April at the American Association for Cancer Research (AACR) annual meeting.

New Research in March: Colorectal Cancer, Kidney Health, OR Supply Costs, and More

The March issue of the Journal of the American College of Surgeons (JACS) features new research on topics ranging from colorectal cancer and social vulnerability to operating room supply costs, the rise in school shootings since 1970, and the impact of permitless open carry laws on suicide rates, among others.

A soja aumenta o risco de câncer de mama?

A pergunta está gerando muitos debates. Há alguma conexão entre a soja e o câncer de mama? A soja contém isoflavonas, que são estrogênios vegetais. Os níveis elevados de estrogênio estão vinculados com os riscos de câncer de mama. Entretanto, há estudos que demonstram que os produtos de soja não contêm níveis suficientemente elevados de estrogênio para aumentar as chances de desenvolvimento de câncer de mama.

¿La soja aumenta el riesgo de cáncer de mama?

Ha generado varios debates. ¿Hay alguna conexión entre la soja y el cáncer de mama? La soja contiene isoflavonas, que son los estrógenos vegetales. Se han relacionado los niveles altos de estrógeno con un mayor riesgo de cáncer de mama. Sin embargo, hay estudios que demuestran que los productos de soja no contienen niveles de estrógeno lo suficientemente altos como para aumentar las probabilidades de desarrollar cáncer de mama.

APOLLO researchers uncover new target for ovarian cancer treatment

Scientists have identified a new target in ovarian cancer that is particularly vulnerable to chemotherapy. The discovery will allow researchers to better predict how this cancer will behave, particularly the most common and lethal, high-grade serous ovarian cancer (HGSOC). Ovarian cancer is one of the leading causes of cancer deaths among women.

Robotic surgery expertise increases odds for those who battle stomach cancer like Toby Keith

Toby Keith, John Wayne and Fred Rogers are among many famous figures who passed from stomach cancer, a particularly deadly form of  cancer. Now, robotic surgery is improving the odds for cancer patients. Matthew Porembka, M.D. is part of a…

Launch of a pioneering translational research programme in Europe

– The TRIP initiative establishes three new joint laboratories that bring together fundamental biomedical research and clinical research with the aim of accelerating the delivery of results to patients.
– TRIP will focus on emerging fields such as immuno-oncology, inflammation, and cellular senescence.

Call for Papers and Participation: Joint International Conference on ‘Cutting-edge Nanotechnologies for Good Health and Well-being’

The Faculty of Medicine at Chulalongkorn University, cordially invites all those who are interested to attend the joint international conference on “CUTTING-EDGE NANOTECHNOLOGIES FOR GOOD HEALTH AND WELL-BEING” from July 9-12, 2024 between 8:00 and 18:00 hrs. at Chulalongkorn University and Mandarin Hotel, Bangkok, Thailand.

Case Western Reserve University-led research team discovers new method to test for oral cancer

A team of researchers, led by a clinician scientist at the Case Western Reserve University School of Dental Medicine, has discovered a noninvasive, low-cost test to detect oral cancer, monitor precancerous lesions and determine when a biopsy is warranted.

Baylor Scott & White doctor discusses why cancer is impacting more young people

David Winter, MD, at Baylor Scott & White Health, discusses why cancer is impacting more young people. What You Need to Know: People aged 50 and older are living longer because of better cancer detection and treatments. Cancer diagnosis in…

Cleveland Clinic Researchers Uncover How Virus Causes Cancer, Point to Potential Treatment

Cleveland Clinic researchers have discovered a key mechanism used by Kaposi’s sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8), to induce cancer. The research points to effective new treatment options for KSHV-associated cancers, including Kaposi’s sarcoma, primary effusion lymphoma, and HHV8-associated multicentric Castleman disease.

LJI welcomes new faculty member Miguel Reina-Campos, Ph.D.

Cancer researcher Miguel Reina-Campos, Ph.D., has joined the faculty of La Jolla Institute for Immunology (LJI) as an Assistant Professor to lead the Laboratory of Tissue Immune Networks. His laboratory at LJI aims to investigate the basis of CD8+ T cell tissue immunity to improve life-saving cancer immunotherapies.

New model of key brain tumor feature could help scientists understand how to develop new treatments

Researchers at the University of Michigan Health Rogel Cancer Center are exploiting a unique biological feature of glioblastoma to gain a better understanding of how this puzzling brain cancer develops and how to target new treatments against it. The team developed human and mouse models of glioblastoma oncostreams and examined multiple factors in the tumor microenvironment that could impact how oncostreams develop and how to reverse them.

Five Signs of Colorectal Cancer You Shouldn’t Ignore – Even if You’re a Younger Adult

The recent Cancer Facts & Figures 2024 report from American Cancer Society (ACS) researchers revealed a stark increase in colorectal cancer (CRC) incidence among Americans under the age of 55. In just two decades, CRC has moved up from being the fourth leading cause of cancer death in both younger men and women, to first in men and second in women.

Long-term survivors of childhood cancer at higher risk of death following heart issues; threshold for treating risk factors should be lower

New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center indicates that survivors of childhood cancer are at a significantly higher risk of death following a major cardiovascular event — including heart failure, heart attack or stroke — than the general public.

Case Western Reserve receives NIH funding to study long-term health effects of East Palestine, Ohio, train derailment

The National Institutes of Health (NIH) has awarded researchers at Case Western Reserve University a grant to begin studying the possible long-term health effects of exposure to hazardous chemicals from the East Palestine, Ohio, train derailment.

Dana-Farber and Gustave Roussy to hold third Transatlantic Exchange: Annual scientific conference dedicated to advancing Oncology research and practice

Dana-Farber Cancer Institute (Boston, MA, USA) and Gustave Roussy (Grand Paris, Villejuif, France) have announced that the third Transatlantic Exchange in Oncology Conference will address: Liquid Biopsy as an Emerging Approach in Precision Cancer Medicine.The meeting, supported by L’Institut Servier, will be held in-person (witha virtual attendance option) on April 12, 2024, at the Revere Hotel Boston Common and livestreamed virtually on Medscape’s platform.

People With Incarceration History Less Likely to Receive Health Care, Including Cancer Screening in the U.S.

A new study led by researchers at the American Cancer Society (ACS) shows people with an incarceration history had worse access to and receipt of healthcare, including physical exams, blood pressure, blood sugar and cholesterol tests, as well as dental check-ups and breast and colorectal cancer screenings compared with people without incarceration history in the United States. The findings are published today in the Journal of the American Medical Association (JAMA) Health Forum.

Kidney cancer treatments and tumor biology can activate different immune-modifying processes in patients

The findings out of Dana-Farber Cancer Institute highlight that the mechanisms of immune modulation are different in patients treated with immunotherapy and anti-angiogenic combinations. The results also point to the role of tumor biology in the diversity and actions of tumor-infiltrating immune cells brought into action by these treatments. The findings might be important for predicting or understanding treatment outcomes in advanced kidney cancer.

UNC Lineberger named as a national research hub for NIH cancer screening study

UNC Lineberger Comprehensive Cancer Center has been selected as one of nine national research sites for the National Cancer Institute’s newly launched Cancer Screening Research Network, which will evaluate promising and emerging cancer screening technologies.

U of T-led study finds positive support from parents and clinicians for pediatric cancer pain management app

A recent study led by Assistant Professor Lindsay Jibb of the Lawrence Bloomberg Faculty of Nursing and Scientist at The Hospital for Sick Children (SickKids) found that parents of young children with cancer, along with pediatric cancer clinicians are in favour of an app-based solution that Jibb and her team are creating, to help parents manage their child’s cancer pain at home.

National Breast Cancer Foundation Gives Grant to Help Breast Care Center Patients at Texas Tech Physicians of El Paso

In addition to assisting with access to care, such as transportation and general needs like groceries, the grant will allow the Breast Care Center to screen for mental and emotional distress using tablets. Currently, patients participate in an online distress screening survey that prompts questions about financial and psychosocial stressors in a patient’s life.

In Memoriam: Jonathan W. Uhr, M.D., renowned immunologist and longtime Chair of Microbiology

Jonathan W. Uhr, M.D., Professor Emeritus of Immunology at UT Southwestern Medical Center, who discovered how antibodies are made and developed a technique that led to the early detection of cancer cells, died Feb. 15. He was 96. Dr. Uhr was a member of the National Academy of Sciences and the American Academy of Arts and Sciences.